Annette S. Gross

3.7k total citations
94 papers, 2.8k citations indexed

About

Annette S. Gross is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Annette S. Gross has authored 94 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 27 papers in Oncology and 20 papers in Pharmacology. Recurrent topics in Annette S. Gross's work include Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (20 papers) and Antibiotics Pharmacokinetics and Efficacy (14 papers). Annette S. Gross is often cited by papers focused on Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (20 papers) and Antibiotics Pharmacokinetics and Efficacy (14 papers). Annette S. Gross collaborates with scholars based in Australia, Germany and United States. Annette S. Gross's co-authors include Michel Eichelbaum, Andrew J. McLachlan, S.‐Hakki Onen, Claude Dubray, Abdelkrim Alloui, Vidya Perera, Gillian M. Shenfield, Janelle M. Hoskins, Gerd Mikus and Hongmei Xu and has published in prestigious journals such as PLoS ONE, Physical Review B and Chemosphere.

In The Last Decade

Annette S. Gross

94 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette S. Gross Australia 30 823 639 496 423 407 94 2.8k
Sebastian Härtter Germany 33 709 0.9× 844 1.3× 360 0.7× 417 1.0× 471 1.2× 81 3.8k
Fatemeh Akhlaghi United States 34 536 0.7× 482 0.8× 395 0.8× 519 1.2× 846 2.1× 105 3.8k
Hermann R. Ochs United States 30 553 0.7× 497 0.8× 313 0.6× 409 1.0× 366 0.9× 117 2.8k
Kazunobu Sugawara Japan 28 544 0.7× 571 0.9× 362 0.7× 303 0.7× 281 0.7× 88 1.8k
Norio Yasui‐Furukori Japan 29 521 0.6× 347 0.5× 465 0.9× 414 1.0× 229 0.6× 133 2.4k
Allen J. Sedman United States 32 531 0.6× 661 1.0× 420 0.8× 513 1.2× 603 1.5× 86 3.2k
Gunnel Tybring Sweden 40 2.0k 2.4× 765 1.2× 929 1.9× 726 1.7× 662 1.6× 73 4.2k
Aziz Karim United States 37 722 0.9× 1.2k 1.9× 668 1.3× 456 1.1× 1.2k 3.0× 127 5.5k
Roberto Goméni Italy 33 288 0.3× 718 1.1× 320 0.6× 381 0.9× 582 1.4× 179 3.3k
David E. Moody United States 41 1.1k 1.3× 714 1.1× 516 1.0× 779 1.8× 1.5k 3.7× 192 5.5k

Countries citing papers authored by Annette S. Gross

Since Specialization
Citations

This map shows the geographic impact of Annette S. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette S. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette S. Gross more than expected).

Fields of papers citing papers by Annette S. Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette S. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette S. Gross. The network helps show where Annette S. Gross may publish in the future.

Co-authorship network of co-authors of Annette S. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Annette S. Gross. A scholar is included among the top collaborators of Annette S. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette S. Gross. Annette S. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tompson, Debra, Carwyn Davies, Nicola Scott, et al.. (2020). Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 46(1). 71–83. 18 indexed citations
2.
McLachlan, Andrew J., et al.. (2017). The role of ethnicity in personalized dosing of small molecule tyrosine kinase inhibitors used in oncology. Translational Cancer Research. 6. 6 indexed citations
3.
Hovelson, Daniel H., Zhengyu Xue, Matthew Zawistowski, et al.. (2016). Characterization of ADME gene variation in 21 populations by exome sequencing. Pharmacogenetics and Genomics. 27(3). 89–100. 34 indexed citations
4.
5.
Hu, Chaoying, Jingying Jia, Kelly Dong, et al.. (2015). Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial. PLoS ONE. 10(3). e0121264–e0121264. 14 indexed citations
6.
Perera, Vidya, Annette S. Gross, Hongmei Xu, & Andrew J. McLachlan. (2011). Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. Journal of Pharmacy and Pharmacology. 63(9). 1161–1168. 56 indexed citations
7.
Xu, Hongmei, et al.. (2006). Stereoselective analysis of hydroxybupropion and application to drug interaction studies. Chirality. 19(3). 163–170. 28 indexed citations
8.
Gross, Annette S., et al.. (2005). Pharmacokinetics of Adefovir after Oral Administration of Adefovir Dipivoxil 10 mg in Healthy Japanese Males and Japanese Patients with Chronic Hepatitis B. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 36(6). 289–296. 2 indexed citations
9.
Gross, Annette S., et al.. (2003). Real time radiologic evaluation of diffusion properties of transurethral intraprostatic injection. European Urology Supplements. 2(1). 21–21. 1 indexed citations
10.
Hoskins, Janelle M., Annette S. Gross, Gillian M. Shenfield, & Laurent P. Rivory. (2001). High-performance liquid chromatography–electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 754(2). 319–326. 15 indexed citations
11.
Cordato, Dennis, Geoffrey Herkes, Laurence E. Mather, et al.. (2001). Prolonged Thiopentone Infusion for Neurosurgical Emergencies: Usefulness of Therapeutic Drug Monitoring. Anaesthesia and Intensive Care. 29(4). 339–348. 16 indexed citations
12.
Hoskins, Janelle M., et al.. (2001). Characterization of moclobemideN-oxidation in human liver microsomes. Xenobiotica. 31(7). 387–397. 14 indexed citations
13.
Shenfield, Gillian M. & Annette S. Gross. (1999). The cytochrome P450 system and adverse drug reactions. Adverse Drug Reaction Bulletin. 194(1). 739–742. 5 indexed citations
14.
Cordato, Dennis, Annette S. Gross, Geoffrey Herkes, & Laurence E. Mather. (1997). Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac‐thiopentone. British Journal of Clinical Pharmacology. 43(4). 355–362. 18 indexed citations
15.
Maier, Rolf F., et al.. (1995). Acute and chronic fetal hypoxia in monochorionic and dichorionic twins. Obstetrics and Gynecology. 86(6). 973–977. 24 indexed citations
16.
Kee, Anthony J., et al.. (1994). The effect of dipeptide structure on dipeptide and amino acid clearance in rats. Metabolism. 43(11). 1373–1378. 12 indexed citations
17.
Carr, Andrew, Annette S. Gross, Janelle M. Hoskins, Ronald Penny, & David A. Cooper. (1994). Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. AIDS. 8(3). 333–338. 80 indexed citations
18.
Gross, Annette S.. (1993). Satan and Christianity : the Demonization of Christianity in the Writings of Abraham Saba. 58(1). 91–105. 1 indexed citations
19.
Mikus, Gerd, et al.. (1989). The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide. Clinical Pharmacology & Therapeutics. 45(5). 562–567. 58 indexed citations
20.
Gross, Annette S. & Kenneth Brown. (1985). Plasma protein binding of ritodrine at parturition and in nonpregnant women. European Journal of Clinical Pharmacology. 28(4). 479–481. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Härtter Breakdown of academic impact, for papers by Fatemeh Akhlaghi Breakdown of academic impact, for papers by Hermann R. Ochs Breakdown of academic impact, for papers by Kazunobu Sugawara Breakdown of academic impact, for papers by Norio Yasui‐Furukori Breakdown of academic impact, for papers by Allen J. Sedman Breakdown of academic impact, for papers by Gunnel Tybring Breakdown of academic impact, for papers by Aziz Karim Breakdown of academic impact, for papers by Roberto Goméni Breakdown of academic impact, for papers by David E. Moody
Rankless by CCL
2026